GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Piotroski F-Score

Tivic Health Systems (Tivic Health Systems) Piotroski F-Score : 4 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tivic Health Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Tivic Health Systems's Piotroski F-Score or its related term are showing as below:

TIVC' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 5
Current: 4

During the past 5 years, the highest Piotroski F-Score of Tivic Health Systems was 5. The lowest was 4. And the median was 5.


Tivic Health Systems Piotroski F-Score Historical Data

The historical data trend for Tivic Health Systems's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems Piotroski F-Score Chart

Tivic Health Systems Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A N/A 5.00 4.00

Tivic Health Systems Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 N/A N/A 4.00 4.00

Competitive Comparison of Tivic Health Systems's Piotroski F-Score

For the Medical Devices subindustry, Tivic Health Systems's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tivic Health Systems's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -2.116 + -2.125 + -1.76 + -2.243 = $-8.24 Mil.
Cash Flow from Operations was -2.426 + -2.44 + -1.871 + -1.774 = $-8.51 Mil.
Revenue was 0.376 + 0.161 + 0.282 + 0.357 = $1.18 Mil.
Gross Profit was 0.113 + 0.061 + 0.108 + 0.005 = $0.29 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(5.875 + 7.101 + 4.596 + 7.007 + 5.157) / 5 = $5.9472 Mil.
Total Assets at the begining of this year (Dec22) was $5.88 Mil.
Long-Term Debt & Capital Lease Obligation was $0.18 Mil.
Total Current Assets was $4.65 Mil.
Total Current Liabilities was $1.40 Mil.
Net Income was -2.24 + -3.018 + -2.584 + -2.254 = $-10.10 Mil.

Revenue was 0.428 + 0.528 + 0.477 + 0.408 = $1.84 Mil.
Gross Profit was 0.07 + 0.125 + 0.063 + 0.043 = $0.30 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(15.036 + 12.694 + 11.026 + 8.208 + 5.875) / 5 = $10.5678 Mil.
Total Assets at the begining of last year (Dec21) was $15.04 Mil.
Long-Term Debt & Capital Lease Obligation was $0.37 Mil.
Total Current Assets was $5.31 Mil.
Total Current Liabilities was $1.88 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tivic Health Systems's current Net Income (TTM) was -8.24. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tivic Health Systems's current Cash Flow from Operations (TTM) was -8.51. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-8.244/5.875
=-1.40323404

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-10.096/15.036
=-0.67145517

Tivic Health Systems's return on assets of this year was -1.40323404. Tivic Health Systems's return on assets of last year was -0.67145517. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Tivic Health Systems's current Net Income (TTM) was -8.24. Tivic Health Systems's current Cash Flow from Operations (TTM) was -8.51. ==> -8.51 <= -8.24 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.176/5.9472
=0.02959376

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0.367/10.5678
=0.03472814

Tivic Health Systems's gearing of this year was 0.02959376. Tivic Health Systems's gearing of last year was 0.03472814. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=4.652/1.401
=3.32048537

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=5.306/1.878
=2.82534611

Tivic Health Systems's current ratio of this year was 3.32048537. Tivic Health Systems's current ratio of last year was 2.82534611. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Tivic Health Systems's number of shares in issue this year was 1.466. Tivic Health Systems's number of shares in issue last year was 0.097. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.287/1.176
=0.24404762

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.301/1.841
=0.1634981

Tivic Health Systems's gross margin of this year was 0.24404762. Tivic Health Systems's gross margin of last year was 0.1634981. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=1.176/5.875
=0.20017021

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=1.841/15.036
=0.12243948

Tivic Health Systems's asset turnover of this year was 0.20017021. Tivic Health Systems's asset turnover of last year was 0.12243948. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+1+1+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tivic Health Systems has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Tivic Health Systems  (NAS:TIVC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Tivic Health Systems Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tivic Health Systems (Tivic Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Executives
Sheryle Bolton director 55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria director C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst director, officer: Chief Executive Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein officer: Chief Scientific Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia officer: Chief Operating Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach officer: Interim CFO 25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai officer: Chief Financial Officer C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude 10 percent owner 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz officer: Chief Financial Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025